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We used multiple imaging assays to test the hypothesis that GPR6, a constitutively active Gs-coupled
receptor, is present on the cell surface. A pHluorin tag at the N-terminus of rat GPR6 expressed in
human embryonic kidney 293 (HEK293) cells was not accessible to protons, chymotrypsin or anti-
green ﬂuorescent protein antibody, demonstrating that GPR6 is primarily located in intracellular
compartments. Similar intracellular localization of pHluorin-tagged GPR6 was found in striatal neu-
rons, where endogenous GPR6 is expressed. Conﬁrmation of Gs-mediated constitutive activity in
HEK293 cells and striatal neurons led us to conclude that GPR6 can signal from intracellular
compartments.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction out mice did not show overt locomotor aberration, but showed anGPR6 belongs to a family of G-protein coupled receptors
(GPCRs) that includes GPR3 and GPR12. Receptors in this family
have been shown to be constitutively active and stimulate cyclic
adenosine monophosphate (cAMP) production via Gs-protein acti-
vation [1,2]. Although constitutive activity of these receptors has
been known for more than a decade, their physiological roles are
just beginning to be identiﬁed [3–5]. Overexpression of GPR6,
GPR3 or GPR12 in neurons in primary cultures can promote cAMP
mediated neurite growth [4]. In addition, knockdown of endoge-
nous GPR3 expression in cerebellar granule cells caused a signiﬁ-
cant decrease in neurite length [4]. Expression of GPR3 and
GPR12 in ovary is responsible for maintaining high cAMP concen-
trations required for meiotic arrest of oocytes [3,6]. Genetic dele-
tion or decreased expression of GPR3 was shown to relieve
meiotic arrest by decreasing cAMP concentration in oocytes [3,7].
Thus, one of the important functions of these receptors is to pro-
mote cAMP-mediated signaling in the cells in which they are ex-
pressed. GPR6 is highly enriched in the striatal region of the
adult mammalian brain [8], suggesting that this receptor may play
a role in locomotor and/or reward related behaviors. GPR6 knock-chemical Societies. Published by E
phate; CREB, cAMP response
ein; GPCR, G-protein coupled
d).increased propensity to acquire appetitive learning behavior [5].
A few reports have suggested that sphingolipids are the endog-
enous agonists for this receptor family [2,9]. GPR6 was shown to be
expressed on the cell surface of human embryonic kidney 293
(HEK293) cells and internalized upon exposure to putative agonist
sphingosine 1-phosphate [2]. On the other hand, most of the red
ﬂuorescent protein tagged GPR6 appeared to be in intracellular
and perinuclear compartments of Neuro2A cells [4]. In order to re-
solve this discrepancy and to gain further insight into signaling by
GPR6, we assessed the localization of GPR6 in HEK293 cells and
striatal neurons.2. Materials and methods
2.1. Cloning of GPR6 and generation of different expression constructs
Rat GPR6 was cloned by RT-PCR into pEGFP-N1 vector using the
‘In-Fusion’ cloning kit (Clontech, Mountain View, CA, USA). The
primers used were; For- C TCA AGC TTC GAA TTC GCC ACC ATG
AAC GCT AGC GCC GCC and Rev- CCG CGG TAC CGT CGA GAC
CTC ACT GGG GGA CCT (GPR6 speciﬁc sequence is in bold, while
the underlined sequence was designed to be identical to that of
vector insertion site). The resultant expression construct with a
green ﬂuorescent protein (GFP) tag at the C-terminus of GPR6 is la-
beled GPR6G. pDsRed2-N1 and pCMV-Tag2 vectors were used to
subclone GPR6 into expression constructs with a DsRed tag at
the C-terminus (GPR6R) and a ﬂag tag at the N-terminus (FGPR6),lsevier B.V. All rights reserved.
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Fig. 1. Constitutively active rat GPR6 appears to be located in intracellular
compartments of HEK293 cells. (A) Cartoons of GPR6 expression constructs with
ﬂag or pHluorin tag at the N-terminus and GFP or DsRed tag at the C-terminus. F:
Flag, S: Signal sequence, pH: pHluorin, Red: DsRed. (B) Immunostaining of ﬂag
epitope at the N-terminus of GPR6 or D1 receptors. All scale bars represent 20 lm.
(C) Fluorescence associated with pHluorin (pHGPR6), GFP (GPR6G) and DsRed
(GPR6R) tags of GPR6 and D1 receptor with a pHluorin tag at the N-terminus
(pHD1). (D) cAMP content in GPR6-transfected cells is signiﬁcantly greater than in
untransfected (control) HEK293 cells. (P < 0.01, n = 4).
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nal sequence (MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLS) followed
by superecliptic pHluorin tag at the N-terminus of GPR6 was engi-
neered by PCR (pHGPR6). Receptor constructs with a ﬂag tag (FD1)
or pHluorin tag (pHD1) at the N-terminus of dopamine D1 receptor
were provided by Dr. Clare Bergson (Medical College of Georgia).
2.2. Cell culture and transfections
HEK293 cells were plated in minimum essential medium sup-
plemented with 10% horse serum, 0.45% D-glucose, 5 pg/ml insulin,
100 units/ml penicillin and 100 lg/ml streptomycin. Lipofect-
amine 2000 (Invitrogen, Carlsbad, CA, USA) was used to transfect
0.3 lg of DNA per well in a 24-well plate. Immunocytochemistry,
live cell imaging or cAMP assays were performed two days after
transfection. Rat striatal neurons were cultured as previously de-
scribed [10]. Neuronal cultures were transfected with 0.4 lg DNA
per well using calcium phosphate method.
2.3. cAMP assay
HEK293 cells were incubated in serum free medium for 3 h and
then incubated in Ringer’s solution containing 100 lM Ro 20-1724
(a phosphodiesterase inhibitor, Sigma–Aldrich, St. Louis, MO, USA)
for 30 min. Dopamine was included during this 30-minute incuba-
tion for activating D1 receptors. Cells were lysed in 0.1 N HCl and
cAMP content of cell lysate was analyzed using an enzyme immu-
noassay kit from Biomedical Technologies Inc. (Stoughton, MA,
USA).
2.4. Immunocytochemistry
Immunocytochemistry was performed as previously described
[10]. Mouse monoclonal M2-ﬂag antibody (Sigma–Aldrich) or rab-
bit phospho-cAMP response element-binding protein (CREB) anti-
body (Millipore, Temecula, CA, USA) was used at a dilution of
1:1000. FITC and Rhodamine Red-X conjugated secondary antibod-
ies were used for ﬂag and phospho-CREB immunostaining,
respectively.
2.5. Cell surface expression assays
Live cell images were acquired under continuous perfusion of
control buffer (pH 7.4) at the rate of 1/s. Change in ﬂuorescence
caused by brief (10–20 s) application of pH 6.0 buffer or 0.3 mg/ml
chymotrypsin (Sigma–Aldrich) wasmeasured. To obtain themagni-
tude of change causedbypH6.0 buffer or chymotrypsin buffer, aver-
age ﬂuorescence intensity during the last 5 s of buffer application
was compared with that in the presence of control buffer. Chymo-
trypsin and low pH buffers were used to complement each other in
ensuring that residual (presumed to be intracellular) ﬂuorescence
is not due to incomplete cleavage or quenching of pHluorin,
respectively.
2.6. Antibody labeling experiment
Cells expressing pHluorin tagged receptors were washed once
with Ringer’s solution and incubated with 10 lg/ml Alexa Fluor-
594 conjugated polyclonal GFP antibody (Invitrogen) for 15 min
at 37 C. After three washes in Ringer’s solution, Z-stack images
of cells were collected with 1.5 lm optical sections and 0.73 lm
intervals. Fluorescence images were acquired using 488 nM or
543 nM excitation wavelength and 500–550 or 590–720 emission
ﬁlters for pHluorin and GFP antibody, respectively. Z-stack images
were compressed to obtain a projection image and the ﬂuores-
cence intensities of pHluorin and the antibody were measured.All images in this study were acquired with laser-scanning confo-
cal microscope (Carl-Zeiss, Thornwood, NY, USA) and analyzed by
Meta 3.2 software (Carl-Zeiss).
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All analyses were performed by paired Student’s t-test. cAMP
data were obtained from triplicate wells in each experiment and
compared to respective control values within each experiment.
All n values represent the number of independent experiments.3. Results
3.1. Constitutively active GPR6 appears to be located in the
intracellular compartments of HEK293 cells
Confocal immunocytochemistry images show that GPR6 receptor
with a ﬂag epitope at the N-terminus is predominantly located in
intracellular compartments of HEK293 cells. In contrast, the D1
receptor, another striatum-enriched Gs-coupled receptor, is primar-
ily observed along the periphery of theHEK293 cells, suggesting plas-
mamembrane localization for this receptor (Fig. 1B). Live cell images
of HEK293 cells expressing GPR6 (pHGPR6) or D1 (pHD1) receptors
with a pHluorin tag at the N-terminus showed an expression pattern
similar to ﬂag-tagged receptors (Fig. 1C). GPR6 receptors with a GFP
tag or DsRed tag at the C-terminus, also showed intracellular appear-
ance inHEK293 cells (Fig. 1C). GPR6 receptor, with any of the epitope
tags, signiﬁcantly increased cAMP accumulation in HEK293 cells
compared to untransfected cells (Fig. 1D) or D1 transfected cells
(Fig. 3C). These data show that constitutive activity and intracellular
appearance of GPR6 is independent of the nature or location of the
epitope tag. A major limitation of imaging analysis used in Fig. 1
and in earlier studies on GPR6 localization [2,4], is that this method
is qualitative and a small fraction of receptors located on the cell sur-
face would not be readily apparent. Thus, we used three different as-0
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Fig. 2. Cell surface expression of GPR6 was not detected in HEK293 cells by proton
expressing cells in control, pH 6.0, 0.3 mg/ml chymotrypsin buffers. (B) Representative ﬂ
beginning and end of experiment show that the cells expressing the receptor constru
Normalized ﬂuorescence intensities of pHGPR6 or pHD1 receptors. Perfusion of pH 6.0 bu
6.0 and chymotrypsin buffers on ﬂuorescence of pHGPR6 and pHD1 receptors. Data are e
buffer for each cell. *Signiﬁcantly different from control buffer values (P < 0.01, n = 6).says using pHluorin constructs to measure the expression of
receptors on the cell surface relative to intracellular compartments.
3.2. pHluorin tag at the N-terminus of GPR6 is not sensitive to low pH
or chymotrypsin treatment in HEK293 cells
Superecliptic pHluorin is a variant of GFP that is highly sensitive
to pH changes in the physiological range (pKa  7.1) [11]. Low pH
buffer quenches the ﬂuorescence of cell surface receptors, as pHuo-
rin tag at the N-terminus is expected to be on the extracellular side
of G-protein coupled receptors on plasma membrane. Exposure to
pH 6.0 buffer did not affect the pHluorin ﬂuorescence of pHGPR6,
while approximately 80% of pHD1 ﬂuorescence was reversibly
quenched (Fig. 2A–D). These data demonstrate that GPR6 in
HEK293 cells is not detectable at the cell surface by proton acces-
sibility of pHluorin tag. Brief perfusion of chymotrypsin did not af-
fect the ﬂuorescence of pHGPR6, but signiﬁcantly and irreversibly
decreased pHD1 ﬂuorescence (Fig. 2A–D). Residual pHluorin ﬂuo-
rescence in pH 6.0 buffer and after chymotrypsin treatment was
found to be similar in magnitude (Fig. 2D). The residual ﬂuores-
cence values show that the upper limit for the fraction of total
receptors located in intracellular compartments are approximately
20% for D1 receptors and 100% for GPR6.
3.3. pHluorin tag at the N-terminus of GPR6 is not accessible to GFP
antibody in HEK293 cells
The proton and chymotrypsin accessibility assays are somewhat
limited by the sensitivity of pHluorin detection. Furthermore, it is
possible that the intracellular localization of GPR6 may be a result
of endocytosis of constitutively active receptor. To overcome these
two limitations, we labeled live HEK293 cells maintained at 37 C0
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Fig. 3. Surface expression of GPR6 in HEK293 cells was not detected by antibody labeling. (A) Compressed images constructed from Z-stacks of pHluorin ﬂuorescence pictures
of pHGPR6 or pHD1 are shown in green. Staining of the same cells with GFP antibody is shown in red. (B) pHluorin ﬂuorescence intensities of individual cells expressing pHD1
are plotted against corresponding GFP antibody ﬂuorescence values. Fluorescence data points corresponding to the three cells labeled in A are indicated by a, b and c. The
slope (4.7) and intercept (11906) of linear regression line provide a measure of the sensitivity of this assay (R2 = 0.78). None of the pHGPR6 expressing cells has any detectable
antibody staining and are not shown in this graph. (C) cAMP content of cultures expressing pHGPR6 or pHD1 are shown as means ± S.E.M. *Signiﬁcantly greater than the other
two groups (P < 0.01, n = 4).
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Fig. 4. Surface expression of GPR6 could not be detected in striatal neurons by proton or chymotrypsin accessibility. (A) Representative ﬂuorescence images of neurons
expressing pHGPR6 in control, pH 6.0, 0.3 mg/ml chymotrypsin buffers. (B) Representative ﬂuorescence images of pHD1 receptor in different buffers. (C) Normalized
ﬂuorescence intensities of pHGPR6 or pHD1 receptors are presented. (D) Average effects of pH 6.0 and chymotrypsin buffers on ﬂuorescence of pHGPR6 and pHD1 receptors.
*Signiﬁcantly different from control buffer values (P < 0.01, n = 4).
110 S. Padmanabhan et al. / FEBS Letters 583 (2009) 107–112
Fig. 5. Surface expression of GPR6 in striatal neurons could not be detected by
antibody labeling. Representative projection images of pHGPR6 or pHD1 are shown
in green, while GFP antibody staining is shown in red.
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Fig. 6. Constitutive activity of GPR6 in striatal neurons can be demonstrated by
increase in CREB phosphorylation. (A) Representative confocal images of phospho-
CREB immunostaining. Arrows indicate neurons transfected with pHGPR6 or pHD1.
(B) Phospho-CREB ﬂuorescence intensities of receptor transfected neurons are
expressed as percent of untransfected controls. *Signiﬁcantly different from
controls (P < 0.01, n = 6).
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ﬂuorescence and GFP antibody ﬂuorescence in cells expressing
pHD1 receptors (Fig. 3A and B ) showed that GFP antibody labeling
is signiﬁcantly more sensitive in detecting pHluorin tagged recep-
tors. Based on the direct comparison of antibody ﬂuorescence and
detectable pHluorin ﬂuorescence values of pHD1 (Fig. 3B), even less
than 3% of GPR6 expressed on the cell surface should have been de-
tected (in most pHGPR6 expressing cells). However, none of the
pHGPR6 expressing cells showed any GFP antibody staining
(Fig. 3A). In parallel cultures, pHGPR6 was found to be constitu-
tively active and caused a signiﬁcant increase in cAMP accumula-
tion compared to unstimulated pHD1 receptors. Application of
1 lM dopamine signiﬁcantly increased cAMP accumulation in
pHD1 expressing cells (Fig. 1C). Based on the assumption that
pHGPR6 and pHD1 are expressed at comparable levels (statistically
similar pHluorin intensity values; data not shown), constitutive
activity of pHGPR6 is approximately 25% of that of pHD1 stimulated
by dopamine. If constitutively active GPR6 were at the plasma
membrane, it should have been detected by GFP antibody labeling.
3.4. pHGPR6 is located in the intracellular compartments of striatal
neurons
It is possible that a yet-to-be-discovered chaperone or receptor
subunit is required for surface expression of cloned GPR6. This
unidentiﬁed protein/s would be expected to be present in striatal
neurons, as endogenous GPR6 is highly enriched in these cells.
Thus, we next tested the expression of pHGPR6 in primary cultures
of striatal neurons. pHluorin tag of pHGPR6 was found to be inac-
cessible to protons, chymotrypsin or GFP antibody (Figs. 4 and 5).
Similar to the data obtained in HEK293 cells, most of the pHD1
receptor was found on the plasma membrane of striatal neurons
in these three assays (Figs. 4 and 5).
3.5. Expression of pHGPR6 stimulates CREB phosphorylation in
neurons
We could not use a cAMP assay to assess constitutive activity of
GPR6 in striatal neurons because of low transfection efﬁciency inprimary cultures. As an alternative, we measured the intensity of
phospho-CREB immunostaining as a downstream readout of in-
creased cAMP production in neurons. Transfection of pHGPR6 sig-
niﬁcantly increased phospho-CREB immunostaining compared to
that of neighboring untransfected neurons (Fig. 6). Neurons trans-
fected with pHD1 did not show any signiﬁcant increase in phos-
pho-CREB intensity.4. Discussion
We conﬁrmed previously reported observations that GPR6 is a
constitutively active receptor which can stimulate cAMP produc-
tion. The main conclusion that can be drawn from our data is that
GPR6 is located in the intracellular compartments and is capable of
activating Gs-mediated signaling from these compartments. Other
GPCRs that have been found to be capable of signaling from intra-
cellular compartments include GPR30, ß-adrenergic, lysophospha-
tidic acid, platelet activating factor and prostaglandin-E2 receptors.
The latter three GPCRs can activate Gi/Go mediated signaling in
nuclei of different cells [12]. Endogenous as well as heterologously
expressed GPR30 was found primarily on the endoplasmic reticu-
lum [13,14]. Functional Gs-coupled ß-adrenergic receptors were
located on the cell surface as well as on the nuclei of cardiac
112 S. Padmanabhan et al. / FEBS Letters 583 (2009) 107–112myocytes [15]. Data presented in this manuscript support addition
of GPR6 to the list of GPCRs that can signal from within the cell. In
fact, functional GPR6 receptors are present predominantly, if not
exclusively, in the intracellular compartments.
Putative GPR6 agonist sphingosine-1-phosphate can be readily
taken up by cells or generated within the cells by sphingosine ki-
nases [16,17]. Thus, this lipid can access intracellular GPR6 and
constitutive activity of GPR6 might be a reﬂection of intracellular
concentrations of sphingosine-1-phosphate. However, Gi-medi-
ated calcium signaling by GPR6, but not Gs-mediated cAMP con-
centration was increased by exogenous sphigosine-1-phosphate
[2]. Promiscuous coupling of GPR6 to multiple G-proteins and their
differential activation by putative agonists underscore the com-
plexity of GPR6 signaling.
Future imaging and biochemical studies are needed to identify
the intracellular compartments in which GPR6 is located. Availabil-
ity of high afﬁnity antibodies to endogenous GPR6 might facilitate
such studies by circumventing the need to use expression con-
structs. Conﬁrmation of intracellular localization of endogenous
GPR6 will also lead to interesting queries on the mechanisms of
receptor compartmentalization and downstream signaling events.
Our demonstration of the intracellular location of GPR6 in different
expression systems will be useful in designing studies aimed at
identifying novel GPR6 agonist/antagonists.
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